1st Annual Translational Oncology Symposium

Bridging the Gap between Cancer Research and the Clinic

Date: Thursday, November 14th, 2019

Location: The California Academy of Sciences, Golden Gate Park
55 Music Concourse Dr., San Francisco, CA 94118
Time: 8am – 5pm, followed by a Happy Hour networking event

Champions Oncology San Francisco Symposium

Registration is Full

Due to overwhelming response, this event has reached capacity.

Cancer’s complexity is more apparent with every discovery made in the field. Learn from industry leaders about critical successes and challenges that they face in this ever-changing therapeutic area.

Gain insights on how to support your translational oncology and Immuno-Oncology programs from the bench to the clinic, by attending Champions Oncology’s Translational Oncology Symposium in San Francisco in November.

You may join the wait list by completing the form. If a we receive a cancellation, we will notify you as soon as possible.

Who should attend?

R&D, discovery, preclinical and translational teams from pharma, biotech, and academia

Speaker Presentations

Gina Wei, PhD

QED Therapeutics – Director, Translational Medicine

Case studies of utilizing PDX models for tumor-agnostic anti-cancer molecular label targeting rare gene alterations

Stephen Dann, PhD

Pfizer – Associate Research Fellow

Cell cycle intervention beyond palbociclib; preclinical discovery of the CDK2/4/6 inhibitor PF-06873600

Rathin Das, PhD, MBA

Synergys Biotherapeutics, Inc. – CEO

Targeting Vasculogenic Mimicry in Triple Negative Breast Cancer

Grace Lee, PhD

REVOLUTION Medicines – Scientist II, Cancer Pharmacology

Leveraging PDX models to explore SHP2i-sensitive genotypes

Kevin Yang, PhD

REVOLUTION Medicines – Scientist II, Cancer Pharmacology

Bi-steric mTOR inhibitors selectively inhibit mTORC1 and demonstrate marked efficacy in preclinical models

Amy Wesa, PhD

Champions Oncology – Director, Immuno-Oncology Research

Emerging preclinical models in oncology: ex vivo platforms and humanized mouse models

Greg Bannish, PhD

Champions Oncology – Head of Flow Cytometry

Optimizing flow cytometry results during preclinical and clinical drug development

Janell Richardson, PhD

Taconic Biosciences – Field Application Specialist

The Jh (B-cell deficient) mouse in the current IO landscape

Sourav Bandyopadhyay, PhD

University of California, San Francisco – Associate Professor, Bioengineering & Therapeutic Sciences

Targeting a mitotic driver of tumor evolution and EGFR TKI resistance in NSCLC

Ray Price, PhD, EMBA

PhenoVista Biosciences – VP, Business Development

Novel imaging applications for models of the tumor microenvironment

Sharsti Sandall, PhD

Seattle Genetics, Principal Scientist, Cancer Biology

Using PDX models to better understand ADC biology

Join us for a day full of scientific insights and professional networking at Champions Oncology Translational Oncology Symposium!

A continental breakfast and coffee will be provided prior to the start of the symposium, as well as lunch will be provided onsite. Happy Hour with hors d’oeuvres and drinks, will be provided following the Symposium.

Complimentary access to the Academy of the Sciences Nightlife event onsite at 6pm will be provided.

Register now to attend!

Sponsored Happy Hour with hors d’oeuvres and drinks will be provided following Symposium